|
|
Longitude Capital Management Co., LLC is a private equity and venture capital firm specializing in investments in all stages of development, from privately-held seed stage to publicly-traded later stage life sciences companies. The firm also invests in PIPEs. It primarily invests in the medical devices, biotechnology, specialty pharmaceuticals including drug-device combinations, and pharmaceutical development sectors. In medical devices, the firm has a preference for early stage companies, and in the case of the biotechnology sector, it prefers to invest in more mature companies. Longitude seeks to invest $10 million to $30 million over the life of each portfolio company, but its initial investment can be much smaller, particularly in early stage opportunities. It prefers to lead or co-lead its investments and requires a seat on the Board of Directors of its portfolio companies. Longitude Capital was founded in 2006 and is based in Menlo Park, California with an additional office in Greenwich, Connecticut. Since 2006, Longitude Capital has raised over $1.8 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles.
|
